Project Frazier 3 Regulatory Clinical Evaluation

NACompletedINTERVENTIONAL

Enrollment

379

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

June 18, 2018

Study Completion Date

June 18, 2018

Conditions

Diabetes MellitusHealthy Volunteers

Interventions

DEVICE

Frazier 3 Verio

In vitro diagnostic device (IVDD)

DEVICE

Frazier 3 UltraPlus

In vitro diagnostic device (IVDD)

Trial Locations (4)

Institut für Diabetes-Technologie, Ulm

Diabetes Centre, Birmingham

Royal Infirmary of Edinburgh, Edinburgh

Centre for Health Science, Inverness

All Listed Sponsors

collaborator

Institute for Diabetes-Technology GmbH

UNKNOWN

lead

LifeScan Scotland Ltd

INDUSTRY

NCT03515421 - Project Frazier 3 Regulatory Clinical Evaluation | Biotech Hunter | Biotech Hunter